.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Farmers Insurance
US Army
Colorcon
Covington
Accenture
Cantor Fitzgerald
US Department of Justice
Citi
Dow

Generated: June 24, 2017

DrugPatentWatch Database Preview

MEDROXYPROGESTERONE ACETATE Drug Profile

« Back to Dashboard

What is the patent landscape for Medroxyprogesterone Acetate, and what generic Medroxyprogesterone Acetate alternatives are available?

Medroxyprogesterone Acetate is a drug marketed by Sandoz Inc, Duramed Pharms Barr, Teva Pharms Usa, Barr, and Usl Pharma. and is included in six NDAs.

The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are nineteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.

Summary for Tradename: MEDROXYPROGESTERONE ACETATE

Patents:0
Applicants:5
NDAs:6
Suppliers / Packagers: see list15
Bulk Api Vendors: see list40
Clinical Trials: see list924
Patent Applications: see list7,102
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEDROXYPROGESTERONE ACETATE at DailyMed

Pharmacology for Tradename: MEDROXYPROGESTERONE ACETATE

Ingredient-typeProgesterone Congeners
Drug ClassProgestin
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
MEDROXYPROGESTERONE ACETATE
medroxyprogesterone acetate
INJECTABLE;INJECTION078711-001May 20, 2009ABRXNoNo► Subscribe► Subscribe
Barr
MEDROXYPROGESTERONE ACETATE
medroxyprogesterone acetate
TABLET;ORAL040159-001Aug 9, 1996ABRXNoNo► Subscribe► Subscribe
Duramed Pharms Barr
MEDROXYPROGESTERONE ACETATE
medroxyprogesterone acetate
TABLET;ORAL040311-003Dec 1, 1999DISCNNoNo► Subscribe► Subscribe
Barr
MEDROXYPROGESTERONE ACETATE
medroxyprogesterone acetate
TABLET;ORAL040159-002Aug 9, 1996ABRXNoNo► Subscribe► Subscribe
Duramed Pharms Barr
MEDROXYPROGESTERONE ACETATE
medroxyprogesterone acetate
TABLET;ORAL040311-001Dec 1, 1999DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Express Scripts
Daiichi Sankyo
Colorcon
Federal Trade Commission
Chubb
Fish and Richardson
Citi
US Department of Justice
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot